Holen Sie sich die Stockscreener-App
48.35
0.39%
-0.19
Vorhandelsmarkt:
47.30
-1.05
-2.17%
Schlusskurs vom Vortag:
$48.54
Offen:
$48.23
24-Stunden-Volumen:
529.13K
Relative Volume:
0.59
Marktkapitalisierung:
$2.46B
Einnahmen:
$534.53M
Nettoeinkommen (Verlust:
$-11.45M
KGV:
-200.54
EPS:
-0.2411
Netto-Cashflow:
$48.28M
1W Leistung:
-1.89%
1M Leistung:
+28.05%
6M Leistung:
+54.67%
1J Leistung:
+30.71%
1-Tages-Spanne:
$46.61
$48.84
1-Wochen-Bereich:
$46.61
$49.98
52-Wochen-Spanne:
$25.36
$49.98
Atricure Inc Stock (ATRC) Company Profile
Firmenname
Atricure Inc
Sektor
Telefon
513-755-4100
Adresse
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
48.35 | 2.42B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
376.86 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.11 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.06 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
240.10 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.03 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-18 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-02-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-04-23 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2021-08-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Bestätigt | Needham | Buy |
| 2020-11-06 | Bestätigt | Needham | Buy |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-24 | Bestätigt | Needham | Buy |
| 2019-08-13 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-04 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Stifel | Buy |
| 2018-06-18 | Bestätigt | Needham | Buy |
| 2018-04-27 | Bestätigt | Needham | Buy |
| 2018-01-16 | Bestätigt | Needham | Buy |
| 2017-11-02 | Bestätigt | Needham | Buy |
| 2017-07-28 | Bestätigt | Needham | Buy |
| 2017-05-30 | Fortgesetzt | Piper Jaffray | Overweight |
| 2016-06-30 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2015-10-28 | Bestätigt | Needham | Buy |
| 2015-10-06 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-06 | Bestätigt | Needham | Buy |
Alle ansehen
Atricure Inc Aktie (ATRC) Neueste Nachrichten
A Look at AtriCure Inc (ATRC) After 3.0% Gain -- GF Value $39.53 vs Price $48.98 - GuruFocus
AtriCure stock hits 52-week high at 48.47 USD - Investing.com
AtriCure stock hits 52-week high at 48.47 USD By Investing.com - Investing.com Canada
AtriCure Stock: Promising Cardiovascular Surgical Platform (NASDAQ:ATRC) - Seeking Alpha
Advisors Capital Management LLC Takes Position in AtriCure, Inc. $ATRC - MarketBeat
Bank of America Corp DE Buys 92,830 Shares of AtriCure, Inc. $ATRC - MarketBeat
134,207 Shares in AtriCure, Inc. $ATRC Acquired by Rice Hall James & Associates LLC - MarketBeat
AtriCure (NASDAQ:ATRC) Hits New 52-Week HighTime to Buy? - MarketBeat
Assenagon Asset Management S.A. Buys New Position in AtriCure, Inc. $ATRC - MarketBeat
AllianceBernstein L.P. (ATRC) reports 5.5% beneficial ownership in AtriCure - Stock Titan
AtriCure Inc. (ATRC) Holds Steady at $43.59 as Range-Bound Trading PersistsTrading Ideas - vinanet.vn
AtriCure stock hits 52-week high at $43.19 By Investing.com - Investing.com Australia
AtriCure stock hits 52-week high at $43.19 - Investing.com
More than 500,000 hours of development, innovation, testing, and refinement across three generations have shaped the AtriClip portfolio into what it is today. - t.co
AtriCure, Inc.Common Stock (ATRC) Stock Price, News, Quote & History - FinancialContent
AtriCure Inc (ATRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel Growth - Yahoo Finance
A Look at AtriCure Inc (ATRC) After 3.1% Gain -- GF Value $39.42 vs Price $42.95 - GuruFocus
AtriCure (NASDAQ:ATRC) Sets New 12-Month HighHere's Why - MarketBeat
ATRC: Strong growth, innovation, and clinical trial catalysts drive robust financial and market expansion - TradingView
Discipline and Rules-Based Execution in ATRC Response - Stock Traders Daily
AtriCure director Karen Prange sells $138,283 in stock By Investing.com - Investing.com UK
AtriCure director Maggie Yuen sells $134,470 in stock By Investing.com - Investing.com South Africa
AtriCure Inc (ATRC) Stock News Today - TradingKey
Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors - fool.com
An AtriCure Director Sold $905,000 in Stock. Here's How to Read It - fool.com
AtriCure Inc (ATRC) Director Karen Prange Sells 3,564 Shares - GuruFocus
AtriCure (NASDAQ:ATRC) Director Sells 3,500 Shares - marketbeat.com
AtriCure (NASDAQ:ATRC) Director Sells $138,283.20 in Stock - marketbeat.com
AtriCure director Maggie Yuen sells $134,470 in stock - Investing.com
Director At AtriCure Sells $134K Of Stock - Benzinga
AtriCure director Karen Prange sells $138,283 in stock - Investing.com
AtriCure, Inc. (ATRC) director sells 3,564 shares at $38.80 - Stock Titan
AtriCure (ATRC) director Maggie Yuen reports sale of 3,500 shares - Stock Titan
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
AtriCure director Maggie Yuen sells 3,500 shares worth $134,470 - Bitget
AtriCure (ATRC) Holds Near $39.49 as Resistance at $41.46 Caps Near-Term UpsideTrend Continuation Trade - vinanet.vn
AtriCure, Inc. SEC Filing (Aug 5, 2026) - stocktitan.net
AtriCure (ATRC) insider plans NASDAQ sale of 3,564 awarded shares - Stock Titan
We Think AtriCure's (NASDAQ:ATRC) Profit Is Only A Baseline For What They Can Achieve - Moomoo
AtriCure, Inc. (ATRC) Stock Analysis: Exploring a Potential 22.25% Upside in the Healthcare Sector - DirectorsTalk Interviews
AtriCure, Inc. $ATRC Stock Position Raised by First Trust Advisors LP - MarketBeat
Will AtriCure’s (ATRC) Profit Turn and ESOP Share Plans Recast Its Investment Narrative? - simplywall.st
Form 4 AtriCure Inc For: 3 August By Investing.com - Investing.com Nigeria
AtriCure, Inc. (ATRC) CEO makes 4,700-share stock gifts to family, charity - Stock Titan
Sei Investments Co. Has $7.44 Million Position in AtriCure, Inc. $ATRC - MarketBeat
Arrowstreet Capital Limited Partnership Takes Position in AtriCure, Inc. $ATRC - MarketBeat
A Look at AtriCure Inc (ATRC) After 6.0% Decline -- GF Value $39 - GuruFocus
Board Member At AtriCure Exercises Options Worth $491K - benzinga.com
Insider Selling: Vinayak Doraiswamy Unloads $233K Of AtriCure Stock - Benzinga
AtriCure (ATRC) Insider Sale: Chief Mktg & Strategy Officer Just - GuruFocus
Finanzdaten der Atricure Inc-Aktie (ATRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):